Amneal Pharmaceuticals, Inc. (AMRX) Stock Overview
Explore Amneal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Amneal Pharmaceuticals, Inc. (AMRX)
Key Financials
Key Financials
Market Cap
6.5B
P/E Ratio
41.31
EPS (TTM)
$0.90
ROE
-3.27%
AMRX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Amneal Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AMRX on the NASDAQ shows an RSI of 67.82, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.28 for the NASDAQ listing.
Key metrics behind Amneal Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of 41.31 and a market capitalization of 6.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMRX on the NASDAQ.